Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils.

Förster, Anja, Falcone, Franco H., Gibbs, Bernhard F., Preussner, Liane M., Fiebig, Britta S., Altunok, Hülya, Seeger, Jens M., Cerny-Reiterer, Sabine, Rabenhorst, Anja, Papenfuss, Kerstin, and others. (2013) Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils. Leukemia & Lymphoma, 54 (4). pp. 835-842. ISSN 1042-8194. (doi:10.3109/10428194.2012.731600) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:45706)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL: http://informahealthcare.com/doi/abs/10.3109/10428...

Abstract

Basophilia is associated with allergic and parasitic diseases and advanced chronic myeloid leukemia. In the present study, we characterized the expression and function of the death receptors Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors in basophils from healthy donors compared to neoplastic basophils. Peripheral blood basophils obtained from healthy donors (HD-PBB) and from patients with chronic myeloid leukemia (CML-PBB) were found to express high levels of Fas/CD95 and low levels of TRAIL-R2, whereas the basophil-like chronic myeloid leukemia cell line KU-812 expressed significant levels of TRAIL-R1 and TRAIL-R2. HD-PBB underwent apoptosis in response to anti-Fas/CD95, but showed resistance to TRAIL, unless they were co-treated with actinomycin D. Interestingly, CML-PBB and KU-812 cells exhibited the opposite response pattern with resistance to anti-Fas/CD95, but significant susceptibility to TRAIL-induced apoptosis. Our data show that anti-Fas/CD95 and TRAIL differentially regulate apoptosis of normal and neoplastic human basophils, which may direct the development of novel therapeutic strategies.

Item Type:	Article
DOI/Identification number:	10.3109/10428194.2012.731600
Subjects:	Q Science > QP Physiology (Living systems) > QP506 Molecular biology Q Science > QR Microbiology > QR180 Immunology R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions:	Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User:	Bernhard F. Gibbs
Date Deposited:	02 Dec 2014 18:13 UTC
Last Modified:	16 Nov 2021 10:18 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/45706 (The current URI for this page, for reference purposes)

University of Kent Author Information

Gibbs, Bernhard F..

Creator's ORCID:
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.